Literature DB >> 192430

Adjuvant chemotherapy in lung cancer: review and prospects.

S S Legha, F M Muggia, S K Carter.   

Abstract

The results of trials testing combined surgery and chemotherapy in lung cancer are reviewed. Fifteen adjuvant trials using various chemotherapeutic agents were analyzed to determine reasons for their lack of success. Current trials with adjuvant therapy in lung cancer are briefly outlined. In addition, analysis of the activity of chemotherapeutic agents in advanced lung cancer and its implications in the design of future adjuvant studies are detailed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 192430     DOI： 10.1002/1097-0142(197704)39:4<1415::aid-cncr2820390410>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  5 in total

1.  Quality of survival in patients with surgically treated bronchial carcinoma.

Authors:  E Nõu; T Aberg
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

2.  Cure rates in small cell and non-small cell carcinoma of the lung utilizing high-dose radiotherapy and chemotherapy.

Authors:  N Akbiyik; L L Alexander
Journal:  J Natl Med Assoc       Date:  1986-03       Impact factor: 1.798

3.  Management of intracranial metastases.

Authors:  M M Sharr; J S Garfield
Journal:  Br Med J       Date:  1978-06-10

4.  Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.

Authors:  M Volm; P Drings; E W Hahn; J Mattern
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

5.  A novel saponin liposomes based on the couplet medicines of Platycodon grandiflorum-Glycyrrhiza uralensis for targeting lung cancer.

Authors:  Chunjing Guo; Yanguo Su; Hui Wang; Min Cao; Ningning Diao; Zhongxin Liu; Daquan Chen; Ming Kong
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.